01.03.2010 • Product

Starna Offers Lifetime Guarantee on CRMs

Photo

Starna Scientific offers a lifetime guarantee on all Starna manufactured Certified Reference Materials (CRMs). The guarantee provides for a free of charge replacement should the assigned values move outside the expanded uncertainty budget within the recertification period of two years. The guarantee is also conditional on the references not having been optically, physically or thermally abused and recertified by Starna at least every two years.

"A lifetime guarantee on CRMs is not offered by anybody else in the market," commented Keith Hulme, Starna's Managing Director. "Starna is one of only six organisations currently accredited by UKAS to ISO 17025 and ISO Guide 34 as a Reference Material producer, and within this elite group there is no other manufacturer in our specific field of expertise, namely, Certified Reference Materials for UV/Visible/NIR spectrophotometer qualification."

Starna's high quality CRMs, which offer guaranteed stability and accuracy of value assignment, are used worldwide across a range of regulated industries, such as leading pharmaceutical manufacturing organisations, as well as accredited laboratories/metrological Q.A. facilities. Starna is able to offer a lifetime guarantee based on the company's forty years experience of quality manufacturing supported by its attention to detail which is coupled with more than ten years of accumulated accredited data.

Starna also provides its expertise in the re-certification of reference materials manufactured by primary NMI laboratories.

 

Visit Starna at the Analytica show in Munich (March 23‐26, 2010) Hall A1, Booth 328

Company

Starna Scientific Ltd.

52-54 Fowler Road
IG6 3UT Hainault

Company contact







Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

most read